DENVER, Mar 08, 2010 (BUSINESS WIRE) -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), in conjunction with DaVita Clinical Research(R), today announced that company representatives will present 20 presentations at the 30th Annual Dialysis Conference (ADC) scheduled for March 6 - 9 in Seattle.
ADC provides a forum for an international group of practitioners and researchers to discuss current developments in the field of dialysis. It is a platform for the nation's leading renal health care providers to learn about new developments in the field of nephrology and CKD care.
"DaVita is proud to present high quality clinical research to the top kidney care providers in the industry," said Allen R. Nissenson, MD, FACP, Chief Medical Officer for DaVita(R). "Our continued dedication to the relentless pursuit of quality and improvement in care delivery benefits the patients we serve in our outpatient dialysis and acute dialysis facilities."
At this year's ADC, DaVita will focus on several key research initiatives in the areas of CKD, Vascular Access, and Home Modalities. Highlights from these scheduled presentations include:
- Title: Patient Characteristics and Factors Influencing the Choice of PD
Presenter:John Moran, MD
- Title: Impact of Phosphorus Additives on ESRD Care
Presenter:Kamyar Kalantar-Zadeh, MD
- Title: Identifying Common Causes and Practical Solutions for Decreasing Central Vein Catheter Dependence for Hemodialysis Access
DaVita is a registered trademark of DaVita Inc. All other trademarks are the property of their respective owners.
About DaVita Inc.
DaVita Inc., a Fortune 500(R) company, is a leading provider of kidney care in the United States, delivering dialysis services and education to patients with chronic kidney failure and end stage renal disease. As of December 31, 2009, DaVita operated or provided administrative services at 1,530 outpatient dialysis facilities and acute units in approximately 720 hospitals located in 43 states and the District of Columbia, serving approximately 118,000 patients. DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. The company's leadership development initiatives and corporate social responsibility efforts have been recognized by Fortune,Modern Healthcare, Newsweek and WorldBlu, among others. For more information, please visitwww.davita.com.
SOURCE: DaVita Inc.
Kelsey Rood, 310-536-2404